You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 23, 2025

CLINICAL TRIALS PROFILE FOR GB1211


✉ Email this page to a colleague

« Back to Dashboard


Clinical Trials for GB1211

Trial IDTitleStatusSponsorPhaseSummary
NCT03809052 ↗ A First in Human Study to Evaluate the Safety, Tolerability and PK of GB1211 in Healthy Subjects Completed Galecto Biotech AB Phase 1 This was a Phase 1, randomized, double-blind, placebo-controlled, first-in-human study in which the safety, tolerability, and pharmacokinetics of orally administered GB1211 will be evaluated in healthy adult subjects and adult subjects with indication of suspected Nonalcoholic steatohepatitis (NASH) and liver fibrosis.
NCT04607655 ↗ A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Orally Administered GB1211 in Participants With Suspected or Confirmed Non-alcoholic Steatohepatitis (NASH) and Liver Fibrosis Withdrawn Covance Phase 1/Phase 2 This study is a randomised, double-blind, placebo controlled, phase Ib trial in subjects with suspected or confirmed non-alcoholic steatohepatitis (NASH) and liver fibrosis
NCT04607655 ↗ A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Orally Administered GB1211 in Participants With Suspected or Confirmed Non-alcoholic Steatohepatitis (NASH) and Liver Fibrosis Withdrawn Galecto Biotech AB Phase 1/Phase 2 This study is a randomised, double-blind, placebo controlled, phase Ib trial in subjects with suspected or confirmed non-alcoholic steatohepatitis (NASH) and liver fibrosis
>Trial ID>Title>Status>Phase>Summary
Showing 1 to 3 of 3 entries

Clinical Trial Conditions for GB1211

Condition Name

1110-0.100.10.20.30.40.50.60.70.80.911.1Head and Neck Squamous Cell CarcinomaHepatic ImpairmentMetastatic Melanoma[disabled in preview]
Condition Name
Intervention Trials
Head and Neck Squamous Cell Carcinoma 1
Hepatic Impairment 1
Metastatic Melanoma 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

2220-0.200.20.40.60.811.21.41.61.822.2Non-alcoholic Fatty Liver DiseaseLiver CirrhosisFibrosis[disabled in preview]
Condition MeSH
Intervention Trials
Non-alcoholic Fatty Liver Disease 2
Liver Cirrhosis 2
Fibrosis 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for GB1211

Trials by Country

+
Trials by Country
Location Trials
United States 1
Netherlands 1
Bulgaria 1
United Kingdom 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

+
Trials by US State
Location Trials
Oregon 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for GB1211

Clinical Trial Phase

16.7%50.0%33.3%000.511.522.53Phase 2Phase 1/Phase 2Phase 1[disabled in preview]
Clinical Trial Phase
Clinical Trial Phase Trials
Phase 2 1
Phase 1/Phase 2 3
Phase 1 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

60.0%20.0%20.0%000.511.522.53RecruitingCompletedNot yet recruiting[disabled in preview]
Clinical Trial Status
Clinical Trial Phase Trials
Recruiting 3
Completed 1
Not yet recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for GB1211

Sponsor Name

trials01122334455667Galecto Biotech ABQPS Holdings LLCProvidence Cancer Center[disabled in preview]
Sponsor Name
Sponsor Trials
Galecto Biotech AB 6
QPS Holdings LLC 1
Providence Cancer Center 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

71.4%28.6%0-101234567891011IndustryOther[disabled in preview]
Sponsor Type
Sponsor Trials
Industry 10
Other 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.